Scott Houlton became a member of the Great Point Partners CEO Advisory Board in 2018 after the sale of Clinical Supplies Management (“CSM”), a GPP II portfolio company.
Mr. Houlton joined CSM as CEO in 2016, completed two European tuck-ins (Belgium and Germany), tripled revenues and 23 months later in September 2018, led the sale of the business to Clinigen, resulting in a 4.9x multiple of invested capital and 125% IRR. Previously, he was President at Catalent Pharma Solutions where, over a five-year period, he increased revenue from $140 million to $450 million and EBITDA from $24 million to $100 million. Prior to Catalent, he was the Chief Operating Officer at Aptuit.
Mr. Houlton graduated cum laude with a bachelor’s degree in finance and in international business from Ohio State University.
- Clinical Supplies Management – clinical trials supplies management
- Catalent Pharma Solutions – drug and biologic development service